169 related articles for article (PubMed ID: 9915317)
1. Targeting effect compartment or central compartment concentration of propofol: what predicts loss of consciousness?
Wakeling HG; Zimmerman JB; Howell S; Glass PS
Anesthesiology; 1999 Jan; 90(1):92-7. PubMed ID: 9915317
[TBL] [Abstract][Full Text] [Related]
2. Comparison of plasma compartment versus two methods for effect compartment--controlled target-controlled infusion for propofol.
Struys MM; De Smet T; Depoorter B; Versichelen LF; Mortier EP; Dumortier FJ; Shafer SL; Rolly G
Anesthesiology; 2000 Feb; 92(2):399-406. PubMed ID: 10691226
[TBL] [Abstract][Full Text] [Related]
3. Estimation of the plasma effect site equilibration rate constant (ke0) of propofol in children using the time to peak effect: comparison with adults.
Muñoz HR; Cortínez LI; Ibacache ME; Altermatt FR
Anesthesiology; 2004 Dec; 101(6):1269-74. PubMed ID: 15564932
[TBL] [Abstract][Full Text] [Related]
4. Study of the time course of the clinical effect of propofol compared with the time course of the predicted effect-site concentration: Performance of three pharmacokinetic-dynamic models.
Coppens M; Van Limmen JG; Schnider T; Wyler B; Bonte S; Dewaele F; Struys MM; Vereecke HE
Br J Anaesth; 2010 Apr; 104(4):452-8. PubMed ID: 20190259
[TBL] [Abstract][Full Text] [Related]
5. Influence of a modified propofol equilibration rate constant (k(e0)) on the effect-site concentration at loss and recovery of consciousness with the Marsh model.
Seo JH; Goo EK; Song IA; Park SH; Park HP; Jeon YT; Hwang JW
Anaesthesia; 2013 Dec; 68(12):1232-8. PubMed ID: 24032636
[TBL] [Abstract][Full Text] [Related]
6. Estimating the plasma effect-site equilibrium rate constant (Ke₀) of propofol by fitting time of loss and recovery of consciousness.
Wu Q; Sun B; Wang S; Zhao L; Qi F
Biol Pharm Bull; 2013; 36(9):1420-7. PubMed ID: 23803230
[TBL] [Abstract][Full Text] [Related]
7. Induction of general anaesthesia by effect-site target-controlled infusion of propofol: influence of pharmacokinetic model and ke0 value.
Thomson AJ; Morrison G; Thomson E; Beattie C; Nimmo AF; Glen JB
Anaesthesia; 2014 May; 69(5):429-35. PubMed ID: 24738800
[TBL] [Abstract][Full Text] [Related]
8. Predictive ability of propofol effect-site concentrations during fast and slow infusion rates.
Sepúlveda PO; Cortínez LI; Recart A; Muñoz HR
Acta Anaesthesiol Scand; 2010 Apr; 54(4):447-52. PubMed ID: 20003124
[TBL] [Abstract][Full Text] [Related]
9. Age progression from vicenarians (20-29 year) to nonagenarians (90-99 year) among a population pharmacokinetic/pharmacodynamic (PopPk-PD) covariate analysis of propofol-bispectral index (BIS) electroencephalography.
Dahaba AA; Xiao Z; Zhu X; Dong H; Xiong L; Rehak P; Zelzer S; Wang K; Reibnegger G
J Pharmacokinet Pharmacodyn; 2020 Apr; 47(2):145-161. PubMed ID: 32100175
[TBL] [Abstract][Full Text] [Related]
10. The influence of target concentration, equilibration rate constant (ke0 ) and pharmacokinetic model on the initial propofol dose delivered in effect-site target-controlled infusion.
Glen JB; Engbers FH
Anaesthesia; 2016 Mar; 71(3):306-14. PubMed ID: 26682512
[TBL] [Abstract][Full Text] [Related]
11. Induction speed is not a determinant of propofol pharmacodynamics.
Doufas AG; Bakhshandeh M; Bjorksten AR; Shafer SL; Sessler DI
Anesthesiology; 2004 Nov; 101(5):1112-21. PubMed ID: 15505446
[TBL] [Abstract][Full Text] [Related]
12. Propofol in rats: testing for nonlinear pharmacokinetics and modelling acute tolerance to EEG effects.
Ihmsen H; Tzabazis A; Schywalsky M; Schwilden H
Eur J Anaesthesiol; 2002 Mar; 19(3):177-88. PubMed ID: 12071237
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic-pharmacodynamic model for propofol for broad application in anaesthesia and sedation.
Eleveld DJ; Colin P; Absalom AR; Struys MMRF
Br J Anaesth; 2018 May; 120(5):942-959. PubMed ID: 29661412
[TBL] [Abstract][Full Text] [Related]
14. Influence of formulation on propofol pharmacokinetics and pharmacodynamics in anesthetized patients.
Calvo R; Telletxea S; Leal N; Aguilera L; Suarez E; De La Fuente L; Martin-Suarez A; Lukas JC
Acta Anaesthesiol Scand; 2004 Sep; 48(8):1038-48. PubMed ID: 15315624
[TBL] [Abstract][Full Text] [Related]
15. Influence of administration rate on propofol plasma-effect site equilibration.
Struys MM; Coppens MJ; De Neve N; Mortier EP; Doufas AG; Van Bocxlaer JF; Shafer SL
Anesthesiology; 2007 Sep; 107(3):386-96. PubMed ID: 17721240
[TBL] [Abstract][Full Text] [Related]
16. Concentration-EEG effect relationship of propofol in rats.
Dutta S; Matsumoto Y; Gothgen NU; Ebling WF
J Pharm Sci; 1997 Jan; 86(1):37-43. PubMed ID: 9002457
[TBL] [Abstract][Full Text] [Related]
17. Use of target controlled infusion to derive age and gender covariates for propofol clearance.
White M; Kenny GN; Schraag S
Clin Pharmacokinet; 2008; 47(2):119-27. PubMed ID: 18193918
[TBL] [Abstract][Full Text] [Related]
18. The influence of age on propofol pharmacodynamics.
Schnider TW; Minto CF; Shafer SL; Gambus PL; Andresen C; Goodale DB; Youngs EJ
Anesthesiology; 1999 Jun; 90(6):1502-16. PubMed ID: 10360845
[TBL] [Abstract][Full Text] [Related]
19. A novel technique to determine an 'apparent ke0 ' value for use with the Marsh pharmacokinetic model for propofol.
Thomson AJ; Nimmo AF; Engbers FH; Glen JB
Anaesthesia; 2014 May; 69(5):420-8. PubMed ID: 24738799
[TBL] [Abstract][Full Text] [Related]
20. Propofol target-controlled infusion modeling in rabbits: Pharmacokinetic and pharmacodynamic analysis.
Chen JY; Yi M; Yao SL; Zhang XP
J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):428-433. PubMed ID: 27376816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
